Ameet Mallik, Executive VP and Head of Oncology for the US at Novartis Oncology highlights the company's culture of 'curious, inspired, and unbossed,' how Novartis differentiates itself in a highly competitive oncology landscape, learnings from recent product launches, and how Novartis is working to make its CAR-T therapy more accessible to all patients.
At Novartis, we do not shy away from competition. It is a good thing and it demonstrates the attractiveness of the market. There is a reason the oncology space is so competitive.
